| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.45 | 1e-11 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |